Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 75

1.

PROSPER: a randomised comparison of surgical treatments for rectal prolapse.

Senapati A, Gray RG, Middleton LJ, Harding J, Hills RK, Armitage NC, Buckley L, Northover JM; PROSPER Collaborative Group.

Colorectal Dis. 2013 Jul;15(7):858-68. doi: 10.1111/codi.12177.

PMID:
23461778
2.

ACPGBI position statement on elective resection for diverticulitis.

Fozard JB, Armitage NC, Schofield JB, Jones OM; Association of Coloproctology of Great Britain and Ireland.

Colorectal Dis. 2011 Apr;13 Suppl 3:1-11. doi: 10.1111/j.1463-1318.2010.02531.x. Review. No abstract available.

PMID:
21366820
3.

Fibrin glue for the treatment of fistulae in ano--a method worth sticking to?

Yeung JM, Simpson JA, Tang SW, Armitage NC, Maxwell-Armstrong C.

Colorectal Dis. 2010 Apr;12(4):363-6. doi: 10.1111/j.1463-1318.2009.01801.x. Epub 2009 Feb 7.

PMID:
19220380
4.

Aspirin and folic acid for the prevention of recurrent colorectal adenomas.

Logan RF, Grainge MJ, Shepherd VC, Armitage NC, Muir KR; ukCAP Trial Group.

Gastroenterology. 2008 Jan;134(1):29-38. Epub 2007 Oct 10.

PMID:
18022173
5.

Recombinant factor VIIa: a useful tool for life-threatening colonic bleeding. Report of a case.

Mitchell JG, Speake WJ, Russell NK, Girling K, Armitage NC.

Dis Colon Rectum. 2007 Dec;50(12):2238-40. Epub 2007 Oct 5. No abstract available.

PMID:
17917781
6.

Complex perirectal sepsis: clinical classification and imaging.

Zbar AP, Armitage NC.

Tech Coloproctol. 2006 Jul;10(2):83-93. Epub 2006 Jun 19. Review.

PMID:
16773294
7.

Enhanced expression of the complement regulatory protein CD55 predicts a poor prognosis in colorectal cancer patients.

Durrant LG, Chapman MA, Buckley DJ, Spendlove I, Robins RA, Armitage NC.

Cancer Immunol Immunother. 2003 Oct;52(10):638-42. Epub 2003 Jun 14.

PMID:
12811528
8.

V-Y advancement flap for treatment of fistula-in-ano.

Amin SN, Tierney GM, Lund JN, Armitage NC.

Dis Colon Rectum. 2003 Apr;46(4):540-3.

PMID:
12682551
9.

Defunctioning loop ileostomy and stapled side-to-side closure has low morbidity.

Amin SN, Memon MA, Armitage NC, Scholefield JH.

Ann R Coll Surg Engl. 2001 Jul;83(4):246-9.

10.

Lateral repair of parastomal hernia.

Amin SN, Armitage NC, Abercrombie JF, Scholefield JH.

Ann R Coll Surg Engl. 2001 May;83(3):206-8.

11.

Risks, costs, and compliance limit colorectal adenoma surveillance: lessons from a randomised trial.

Lund JN, Scholefield JH, Grainge MJ, Smith SJ, Mangham C, Armitage NC, Robinson MH, Logan RF.

Gut. 2001 Jul;49(1):91-6.

12.

The risks of screening: data from the Nottingham randomised controlled trial of faecal occult blood screening for colorectal cancer.

Robinson MH, Hardcastle JD, Moss SM, Amar SS, Chamberlain JO, Armitage NC, Scholefield JH, Mangham CM.

Gut. 1999 Oct;45(4):588-92.

13.

Preoperative carcinoembryonic antigen is related to tumour stage and long-term survival in colorectal cancer.

Chapman MA, Buckley D, Henson DB, Armitage NC.

Br J Cancer. 1998 Nov;78(10):1346-9.

14.

Endoscopic screening of relatives of patients with colorectal cancer.

Hunt LM, Rooney PS, Hardcastle JD, Armitage NC.

Gut. 1998 Jan;42(1):71-5.

15.

Magnetic resonance imaging in the management of fistula in ano.

Scholefield JH, Berry DP, Armitage NC, Wastie ML.

Int J Colorectal Dis. 1997;12(5):276-9.

PMID:
9401841
16.

Chemical and immunological testing for faecal occult blood in screening subjects at risk of familial colorectal cancer.

Hunt LM, Rooney PS, Bostock K, Robinson MH, Hardcastle JD, Armitage NC.

Gut. 1997 Jan;40(1):110-2.

17.

Use of glyceryl trinitrate ointment in the treatment of anal fissure.

Lund JN, Armitage NC, Scholefield JH.

Br J Surg. 1996 Jun;83(6):776-7.

PMID:
8696737
18.

Locally advanced breast cancer: long-term results of a randomized trial comparing primary treatment with tamoxifen or radiotherapy in post-menopausal women.

Willsher PC, Robertson JF, Armitage NC, Morgan DA, Nicholson RI, Blamey RW.

Eur J Surg Oncol. 1996 Feb;22(1):34-7.

PMID:
8846863
19.

Transanal endoscopic microsurgery--initial experience from three centres in the United Kingdom.

Steele RJ, Hershman MJ, Mortensen NJ, Armitage NC, Scholefield JH.

Br J Surg. 1996 Feb;83(2):207-10.

PMID:
8689164
20.

Colonoscopy for all first-degree relatives of patients with colorectal cancer.

Hunt LM, Hardcastle JD, Armitage NC.

Br J Surg. 1995 Dec;82(12):1644. No abstract available.

PMID:
8548228
21.

Five-year prospective study of DNA tumor ploidy and colorectal cancer survival.

Chapman MA, Hardcastle JD, Armitage NC.

Cancer. 1995 Aug 1;76(3):383-7.

PMID:
8625117
22.

The effect of calcium supplements on rectal mucosal proliferation.

Armitage NC, Rooney PS, Gifford KA, Clarke PA, Hardcastle JD.

Br J Cancer. 1995 Jan;71(1):186-90.

23.

Wheat fibre, lactulose and rectal mucosal proliferation in individuals with a family history of colorectal cancer.

Rooney PS, Hunt LM, Clarke PA, Gifford KA, Hardcastle JD, Armitage NC.

Br J Surg. 1994 Dec;81(12):1792-4.

PMID:
7827943
24.

Congenital hypertrophy of the retinal pigment epithelium and mandibular osteomata as markers in familial colorectal cancer.

Hunt LM, Robinson MH, Hugkulstone CE, Clarke B, Vernon SA, Gregson RH, Hardcastle JD, Armitage NC.

Br J Cancer. 1994 Jul;70(1):173-6.

25.

Blood transfusion and survival in colorectal cancer.

Sibbering DM, Locker AP, Hardcastle JD, Armitage NC.

Dis Colon Rectum. 1994 Apr;37(4):358-63.

PMID:
8168414
26.

DNA content of rectal mucosa and rectal mucosal proliferation in individuals at high risk of colorectal cancer.

Rooney PS, Clarke PA, Gifford KA, Hardcastle JD, Armitage NC.

Eur J Cancer Prev. 1994 Jan;3(1):57-61.

PMID:
8130718
27.

Cell kinetics of the in vitro metaphase arrest technique and the clinical applications.

Rooney PS, Clarke PA, Gifford KA, Robinson MH, Hardcastle JD, Durrant LG, Armitage NC.

Eur J Cancer Prev. 1993 Sep;2(5):387-92.

PMID:
8401173
28.

The identification of high and low risk groups for colorectal cancer using rectal mucosal crypt cell production rate (CCPR).

Rooney PS, Clarke PA, Gifford KA, Hardcastle JD, Armitage NC.

Br J Cancer. 1993 Jul;68(1):172-5.

29.

Mural bridging lesions in colonic Crohn's disease.

Poller DN, Armitage NC.

Arch Pathol Lab Med. 1993 May;117(5):550-2.

PMID:
8489349
30.

Hartmann's procedure: an appraisal.

Whiston RJ, Armitage NC, Wilcox D, Hardcastle JD.

J R Soc Med. 1993 Apr;86(4):205-8.

31.

Individuals with a strong family history of colorectal cancer demonstrate abnormal rectal mucosal proliferation.

Rooney PS, Robinson MH, Clarke PA, Hardcastle JD, Armitage NC.

Br J Surg. 1993 Feb;80(2):249-51.

PMID:
8443673
32.

Screening for large bowel neoplasms in individuals with a family history of colorectal neoplasms.

Hunt L, Armitage NC.

Br J Surg. 1992 Dec;79(12):1384-5. No abstract available.

PMID:
1486450
33.

Familial adenomatous polyposis.

Armitage NC.

J R Soc Med. 1992 Feb;85(2):63-5. No abstract available.

34.

The prognostic value of the monoclonal antibody (D5) detected protein, p29, in primary colorectal carcinoma.

Robertson JF, Morris DL, Ellis IO, Armitage NC, Hardcastle JD.

Br J Cancer. 1991 Aug;64(2):379-80. No abstract available.

35.

A prospective evaluation of the effect of tumor cell DNA content on recurrence in colorectal cancer.

Armitage NC, Ballantyne KC, Sheffield JP, Clarke P, Evans DF, Hardcastle JD.

Cancer. 1991 May 15;67(10):2599-604.

PMID:
2015560
36.

Intervention studies in adenoma patients.

Armitage NC.

World J Surg. 1991 Jan-Feb;15(1):29-34. Review.

PMID:
1994602
37.

The influence of tumour cell DNA content on survival in colorectal cancer: a detailed analysis.

Armitage NC, Ballantyne KC, Evans DF, Clarke P, Sheffield J, Hardcastle JD.

Br J Cancer. 1990 Nov;62(5):852-6.

38.

Primary aortoenteric fistula due to recurrent colorectal cancer. Report of a case.

Armitage NC, Ballantyne KC.

Dis Colon Rectum. 1990 Feb;33(2):148-9.

PMID:
2298102
39.

Development of an ELISA to detect early local relapse of colorectal cancer.

Durrant LG, Jones H, Armitage NC, Baldwin RW.

Br J Cancer. 1989 Oct;60(4):533-7.

40.

Randomised, controlled trial of faecal occult blood screening for colorectal cancer. Results for first 107,349 subjects.

Hardcastle JD, Thomas WM, Chamberlain J, Pye G, Sheffield J, James PD, Balfour TW, Amar SS, Armitage NC, Moss SM.

Lancet. 1989 May 27;1(8648):1160-4.

PMID:
2566735
41.

Histopathological assessment of bleeding from polyps of the colon and rectum.

Waldock A, Ellis IO, Armitage NC, Turner DR, Hardcastle JD.

J Clin Pathol. 1989 Apr;42(4):378-82.

42.

Paget's disease of the anus: a clinicopathological study.

Armitage NC, Jass JR, Richman PI, Thomson JP, Phillips RK.

Br J Surg. 1989 Jan;76(1):60-3.

PMID:
2537129
43.

Biodistribution of a monoclonal antibody-methotrexate conjugate (791T/36-MTX) in patients with colorectal cancer.

Ballantyne KC, Perkins AC, Pimm MV, Garnett MC, Clegg JA, Armitage NC, Baldwin RW, Hardcastle JD.

Int J Cancer Suppl. 1988;2:103-8.

PMID:
3162436
44.

Sensitivity of newly established colorectal cell lines to cytotoxic drugs and monoclonal antibody drug conjugates.

Durrant LG, Garnett MC, Gallego J, Armitage NC, Ballantyne KC, Marksman RA, Hardcastle JD, Baldwin RW.

Br J Cancer. 1987 Dec;56(6):722-6.

45.

Quantitation of MHC antigen expression on colorectal tumours and its association with tumour progression.

Durrant LG, Ballantyne KC, Armitage NC, Robins RA, Marksman R, Hardcastle JD, Baldwin RW.

Br J Cancer. 1987 Oct;56(4):425-32.

46.

Colon "cast" in a patient with ischaemic colitis.

Phillips RK, Armitage NC.

Br J Surg. 1987 Aug;74(8):759-60. No abstract available.

PMID:
3651790
47.

Screening for colorectal cancer--the Nottingham experience.

Armitage NC, Hardcastle JD.

Ann Acad Med Singapore. 1987 Jul;16(3):432-6.

PMID:
3435009
48.

Influence of non-steroidal anti-inflammatory drugs on the outcome of faecal occult blood tests in screening for colorectal cancer.

Pye G, Ballantyne KC, Armitage NC, Hardcastle JD.

Br Med J (Clin Res Ed). 1987 Jun 13;294(6586):1510-1.

49.

Imaging of primary and metastatic colorectal carcinoma with monoclonal antibody 791T/36 and the therapeutic potential of antibody-drug conjugates.

Pimm MV, Armitage NC, Ballantyne K, Baldwin RW, Perkins AC, Durrant LG, Garnett MC, Hardcastle JD.

Cancer Detect Prev Suppl. 1987;1:249-62.

PMID:
3480055
50.

In vitro binding and in vivo localization in colorectal cancer of a high affinity monoclonal antibody to carcinoembryonic antigen.

Armitage NC, Perkins AC, Durrant LG, Ellis IO, Ballantyne KC, Harrison RC, Riley AM, Robins RA, Wastie ML, Hardcastle JD.

Br J Surg. 1986 Dec;73(12):965-9.

PMID:
3790959

Supplemental Content

Loading ...
Support Center